AI Verdict
NAVN has stronger fundamentals based on our AI analysis.
NBY vs NAVN Fundamental Comparison
| Metric | NBY | NAVN |
|---|---|---|
| Revenue | $521,000.0 | $702.3M |
| Net Income | $-22.1M | $-398.0M |
| Net Margin | -4,249.7% | -56.7% |
| ROE | N/A | -32.9% |
| ROA | -245.1% | -23.3% |
| Current Ratio | 7.60x | 4.07x |
| Debt/Equity | N/A | 0.10x |
| EPS | $0.76 | $-4.07 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NBY vs NAVN: Frequently Asked Questions
Is NBY or NAVN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NAVN has stronger fundamentals. NBY is rated STRONG SELL (95% confidence) while NAVN is rated SELL (72% confidence). This is not investment advice.
How does NBY compare to NAVN fundamentally?
NovaBay Pharmaceuticals, Inc. has ROE of N/A vs Navan, Inc.'s -32.9%. Net margins are -4,249.7% vs -56.7% respectively.
Which stock pays higher dividends, NBY or NAVN?
NBY has a dividend yield of N/A or no dividend while NAVN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NBY or NAVN for long term?
For long-term investing, consider that NBY has STRONG SELL rating with 95% confidence, while NAVN has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NBY vs NAVN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NBY vs NAVN, the AI consensus favors NAVN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.